neffy®, adrenaline nasal spray, now accessible on the Pharmaceutical Benefits Scheme for anaphylaxis
30/06/2026 16:55
|
Medical, Health & Aged Care
Melbourne, 30 June 2026
CSL Seqirus, part of leading Australian biotechnology company CSL, has today welcomed the news that neffy® adrenaline (epinephrine) nasal spray will be listed on the...